Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 301 AL 315

Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies

Schroeder SK, Joly-Amado A, Gordon MN, Morgan D.

J Neuroimmune Pharmacol. 2016 Mar;11(1):9-25. doi: 10.1007/s11481-015-9637-6. Epub 2015 Nov 4.

Tau Immunotherapy

Sigurdsson EM.

Neurodegener Dis. 2016;16(1-2):34-8. doi: 10.1159/000440842. Epub 2015 Nov 10.

Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease

Maqbool M, Mobashir M, Hoda N.

Eur J Med Chem. 2016 Jan 1;107:63-81. doi: 10.1016/j.ejmech.2015.10.018. Epub 2015 Oct 21.

Developing therapeutic vaccines against Alzheimer's disease

Wisniewski T, Drummond E.

Expert Rev Vaccines. 2016;15(3):401-15. doi: 10.1586/14760584.2016.1121815. Epub 2015 Dec 11.

Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer's disease

Bogachouk AP, Storozheva ZI, Solovjeva OA, Sherstnev VV, Zolotarev YA, Azev VN, Rodionov IL, Surina EA, Lipkin VM.

J Psychopharmacol. 2016 Jan;30(1):78-92. doi: 10.1177/0269881115616393. Epub 2015 Dec 1.

Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin

Samy DM, Ismail CA, Nassra RA, Zeitoun TM, Nomair AM.

Eur J Pharmacol. 2016 Jan 5;770:52-60. doi: 10.1016/j.ejphar.2015.11.046. Epub 2015 Dec 2.

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

Kobayashi H, Ohnishi T, Nakagawa R, Yoshizawa K.

Int J Geriatr Psychiatry. 2016 Aug;31(8):892-904. doi: 10.1002/gps.4405. Epub 2015 Dec 17.

Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?

St-Amour I, Cicchetti F, Calon F.

Acta Neuropathol. 2016 Apr;131(4):481-504. doi: 10.1007/s00401-015-1518-9. Epub 2015 Dec 21.

Accelerating stem cell trials for Alzheimer's disease

Hunsberger JG, Rao M, Kurtzberg J, Bulte JWM, Atala A, LaFerla FM, Greely HT, Sawa A, Gandy S, Schneider LS, Doraiswamy PM.

Lancet Neurol. 2016 Feb;15(2):219-230. doi: 10.1016/S1474-4422(15)00332-4. Epub 2015 Dec 17.

Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds

Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G.

Oxid Med Cell Longev. 2016;2016:7361613. doi: 10.1155/2016/7361613. Epub 2015 Dec 28.

A comparative study of caregiver burden in late-onset depression and Alzheimer's disease

Kazhungil F, Velayudhan R, Kumar M, Thazhe Mangool R.

Psychogeriatrics. 2016 May;16(3):209-15. doi: 10.1111/psyg.12141. Epub 2015 Jul 16.

Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs

Zhang XZ, Qian SS, Zhang YJ, Wang RQ.

Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10.

Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease

Arai H, Umemura K, Ichimiya Y, Iseki E, Eto K, Miyakawa K, Kirino E, Shibata N, Baba H, Tsuchiwata S.

Geriatr Gerontol Int. 2016 May;16(5):644-50. doi: 10.1111/ggi.12516. Epub 2015 Jun 4.

Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: interim results from the long-term, large-scale J-GOLD study in Japan

Arai H, Sumitomo K, Sakata Y, Daidoji K, Takase T, Toyoda T.

Psychogeriatrics. 2016 Mar;16(2):107-15. doi: 10.1111/psyg.12130. Epub 2015 Jun 26.

Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up

Koivisto AM, Hallikainen I, Välimäki T, Hongisto K, Hiltunen A, Karppi P, Sivenius J, Soininen H, Martikainen J.

Int J Geriatr Psychiatry. 2016 Mar;31(3):273-83. doi: 10.1002/gps.4321. Epub 2015 Jul 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias